vs
Side-by-side financial comparison of Armour Residential REIT, Inc. (ARR) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $50.4M, roughly 1.7× Armour Residential REIT, Inc.). Armour Residential REIT, Inc. runs the higher net margin — 420.2% vs -38.1%, a 458.3% gap on every dollar of revenue. On growth, Armour Residential REIT, Inc. posted the faster year-over-year revenue change (297.9% vs 20.2%). Over the past eight quarters, Armour Residential REIT, Inc.'s revenue compounded faster (108.0% CAGR vs 24.8%).
Armour Residential REIT, Inc. is a U.S.-based real estate investment trust that primarily invests in agency residential mortgage-backed securities guaranteed by U.S. government-sponsored entities. It focuses on generating consistent long-term net income for shareholders via strategic asset management and active interest rate risk mitigation.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
ARR vs PRCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $50.4M | $83.1M |
| Net Profit | $211.7M | $-31.6M |
| Gross Margin | — | 64.9% |
| Operating Margin | — | -4.1% |
| Net Margin | 420.2% | -38.1% |
| Revenue YoY | 297.9% | 20.2% |
| Net Profit YoY | 555.9% | -27.9% |
| EPS (diluted) | $2.43 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $83.1M | ||
| Q4 25 | $50.4M | $76.4M | ||
| Q3 25 | $38.5M | $83.3M | ||
| Q2 25 | $33.1M | $79.2M | ||
| Q1 25 | $36.3M | $69.2M | ||
| Q4 24 | $12.7M | $68.2M | ||
| Q3 24 | — | $58.4M | ||
| Q2 24 | $7.0M | $53.4M |
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $211.7M | $-29.8M | ||
| Q3 25 | $159.3M | $-21.4M | ||
| Q2 25 | $-75.6M | $-19.6M | ||
| Q1 25 | $27.3M | $-24.7M | ||
| Q4 24 | $-46.4M | $-18.9M | ||
| Q3 24 | — | $-21.0M | ||
| Q2 24 | $-48.4M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | — | 60.6% | ||
| Q3 25 | — | 64.8% | ||
| Q2 25 | — | 65.4% | ||
| Q1 25 | — | 63.9% | ||
| Q4 24 | — | 64.0% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | — | -40.6% | ||
| Q3 25 | — | -27.8% | ||
| Q2 25 | — | -28.0% | ||
| Q1 25 | — | -39.7% | ||
| Q4 24 | — | -28.9% | ||
| Q3 24 | — | -38.4% | ||
| Q2 24 | — | -50.3% |
| Q1 26 | — | -38.1% | ||
| Q4 25 | 420.2% | -39.1% | ||
| Q3 25 | 413.5% | -25.7% | ||
| Q2 25 | -228.4% | -24.7% | ||
| Q1 25 | 75.2% | -35.8% | ||
| Q4 24 | -366.8% | -27.6% | ||
| Q3 24 | — | -35.9% | ||
| Q2 24 | -693.8% | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $2.43 | $-0.54 | ||
| Q3 25 | $1.49 | $-0.38 | ||
| Q2 25 | $-0.94 | $-0.35 | ||
| Q1 25 | $0.32 | $-0.45 | ||
| Q4 24 | $-0.91 | $-0.34 | ||
| Q3 24 | — | $-0.40 | ||
| Q2 24 | $-1.05 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $63.3M | $245.6M |
| Total DebtLower is stronger | — | $51.7M |
| Stockholders' EquityBook value | $2.3B | $347.7M |
| Total Assets | $21.0B | $487.1M |
| Debt / EquityLower = less leverage | — | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | $63.3M | $286.5M | ||
| Q3 25 | $44.2M | $294.3M | ||
| Q2 25 | $141.2M | $302.7M | ||
| Q1 25 | $49.1M | $316.2M | ||
| Q4 24 | $68.0M | $333.7M | ||
| Q3 24 | — | $196.8M | ||
| Q2 24 | $126.6M | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | — | $51.6M | ||
| Q3 25 | — | $51.6M | ||
| Q2 25 | — | $51.5M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | — | $51.5M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $51.4M |
| Q1 26 | — | $347.7M | ||
| Q4 25 | $2.3B | $365.9M | ||
| Q3 25 | $2.1B | $380.3M | ||
| Q2 25 | $1.7B | $385.8M | ||
| Q1 25 | $1.7B | $389.2M | ||
| Q4 24 | $1.4B | $402.2M | ||
| Q3 24 | — | $241.2M | ||
| Q2 24 | $1.2B | $251.8M |
| Q1 26 | — | $487.1M | ||
| Q4 25 | $21.0B | $508.1M | ||
| Q3 25 | $19.4B | $511.5M | ||
| Q2 25 | $16.2B | $513.1M | ||
| Q1 25 | $15.5B | $519.4M | ||
| Q4 24 | $13.5B | $534.0M | ||
| Q3 24 | — | $374.1M | ||
| Q2 24 | $10.1B | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $124.2M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 0.59× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $124.2M | $-10.3M | ||
| Q3 25 | $-37.8M | $-6.6M | ||
| Q2 25 | $25.0M | $-15.0M | ||
| Q1 25 | $101.5M | $-17.0M | ||
| Q4 24 | $261.5M | $-32.4M | ||
| Q3 24 | — | $-18.8M | ||
| Q2 24 | $27.1M | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-12.2M | ||
| Q3 25 | — | $-9.5M | ||
| Q2 25 | — | $-17.8M | ||
| Q1 25 | — | $-18.8M | ||
| Q4 24 | — | $-33.6M | ||
| Q3 24 | — | $-19.0M | ||
| Q2 24 | — | $-16.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | -15.9% | ||
| Q3 25 | — | -11.4% | ||
| Q2 25 | — | -22.5% | ||
| Q1 25 | — | -27.2% | ||
| Q4 24 | — | -49.2% | ||
| Q3 24 | — | -32.6% | ||
| Q2 24 | — | -31.4% |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 3.4% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 2.7% | ||
| Q4 24 | — | 1.7% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | — | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | 0.59× | — | ||
| Q3 25 | -0.24× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.71× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ARR
Segment breakdown not available.
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
